How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies. However, an easier way is to look at the stocks that ...

Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first. This is a necessary first step in our ...

Axonics Modulation Technologies Inc. Chief Executive Ray Cohen is nothing if not confident about becoming the market leader in his urology device category, despite renewed competition from medtech ...

Axonics Modulation Technologies Inc. (Nasdaq: AXNX) of Irvine said the U.S. Patent and Trademark Office’s decision to review six of seven patent claims from competitor Medtronic PLC (NYSE: MDT) on ...

Wall Street expects a year-over-year decline in earnings on higher revenues when Axonics Modulation Technologies (AXNX) reports results for the quarter ended December 2019. While this widely-known ...

In a report released yesterday, Shagun Singh Chadha from RBC Capital maintained a Hold rating on Axonics Modulation Technologies (AXNX – Research Report), with a price target of $71.00. The company’s ...

Thank you, operator, and thanks everyone for joining the Axonics quarterly results and update call. I'm thrilled to have recently joined Axonics as Vice President of Investor Relations. Presenting on ...

Axonics Modulation Technologies Inc., of Irvine, Calif., reported revenue of $1.3 million for the third quarter of 2019, up from $0.2 million in the same period last year, but below Wall Street's ...

Axonics Modulation Technologies (AXNX – Research Report) received a Hold rating and price target from Wolfe Research analyst Michael Polark yesterday. The company’s shares closed yesterday at $69.36.

* AXONICS MODULATION TECHNOLOGIES INC - MOST EMPLOYEES WILL BE TAKING TEMPORARY 20% CUT IN BASE SALARY FOR REMAINDER OF Q2 2020 DUE TO COVID-19 IMPACT Sign up here. * AXONICS MODULATION TECHNOLOGIES - ...

Axonics Modulation Technologies (AXNX) came out with a quarterly loss of $0.59 per share versus the Zacks Consensus Estimate of a loss of $0.51. This compares to loss of $0.54 per share a year ago.